Redefining Skin Science

Epidermyx Inc. is a biotechnology-driven dermatology company focused on advancing next-generation solutions for pigmentation disorders and aesthetic skin tone control.

Built on novel scientific discoveries in melanocyte biology, our platform enables targeted, non-toxic modulation of pigmentation pathways, offering a safer and more effective alternative to traditional skin-lightening agents.

Current Solutions Fall Short

• Cytotoxic agents like hydroquinone can damage skin cells
• Many treatments are irritating, inconsistent, or irreversible
• Growing regulatory scrutiny limits global availability

Patients and providers are demanding safer, more precise solutions

A New Class: Melanocyte Modulators

Epidermyx is pioneering therapies designed to precisely control melanocyte biology:

• Control melanocyte development and proliferation
• Deliver long-acting yet reversible pigmentation effects
• Maintain skin health without toxicity

This represents a paradigm shift from bleaching to biological precision